|
Volumn 110, Issue 25, 2004, Pages
|
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the population science discussion group.
a a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
C REACTIVE PROTEIN;
ARTICLE;
BLOOD;
CARDIOVASCULAR DISEASE;
CASE CONTROL STUDY;
COST BENEFIT ANALYSIS;
ECONOMICS;
EPIDEMIOLOGY;
FEMALE;
HUMAN;
INFLAMMATION;
MALE;
MASS SCREENING;
PRACTICE GUIDELINE;
PREDICTION AND FORECASTING;
PUBLIC HEALTH SERVICE;
REFERENCE VALUE;
RISK;
RISK ASSESSMENT;
STANDARD;
BIOLOGICAL MARKERS;
C-REACTIVE PROTEIN;
CARDIOVASCULAR DISEASES;
CASE-CONTROL STUDIES;
CONFOUNDING FACTORS (EPIDEMIOLOGY);
COST-BENEFIT ANALYSIS;
FEMALE;
HUMANS;
INFLAMMATION;
MALE;
MASS SCREENING;
PREDICTIVE VALUE OF TESTS;
PUBLIC HEALTH PRACTICE;
REFERENCE VALUES;
RISK;
RISK ASSESSMENT;
|
EID: 28744455066
PISSN: 15244539
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (55)
|
References (0)
|